Cargando…
Bayesian methods: a potential path forward for sepsis trials
BACKGROUND: Given the success of recent platform trials for COVID-19, Bayesian statistical methods have become an option for complex, heterogenous syndromes like sepsis. However, study design will require careful consideration of how statistical power varies using Bayesian methods across different c...
Autores principales: | Tomlinson, George, Al-Khafaji, Ali, Conrad, Steven A., Factora, Faith N. F., Foster, Debra M., Galphin, Claude, Gunnerson, Kyle J., Khan, Sobia, Kohli-Seth, Roopa, McCarthy, Paul, Meena, Nikhil K., Pearl, Ronald G., Rachoin, Jean-Sebastien, Rains, Ronald, Seneff, Michael, Tidswell, Mark, Walker, Paul M., Kellum, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634134/ https://www.ncbi.nlm.nih.gov/pubmed/37940985 http://dx.doi.org/10.1186/s13054-023-04717-x |
Ejemplares similares
-
Lactic versus nonlactic metabolic acidosis: outcomes in critically ill patients
por: Gunnerson, KJ, et al.
Publicado: (2003) -
Alzheimer's disease therapeutic research: the path forward
por: Aisen, Paul S
Publicado: (2009) -
Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward
por: Thiruvengadam, Nikhil, et al.
Publicado: (2015) -
The path forward in early-stage lung cancer
por: Cuppens, Kristof, et al.
Publicado: (2022) -
A Path Forward
por: Elkind, Mitchell S. V., et al.
Publicado: (2020)